Children born to HIV-1 infected mothers were immunized at birth, 1, 3, and 5 months with one of 3 doses of recombinant gp120 vaccines prepared from SF-2 or MN strains of HIV-1. 126 children proved to be HIV-uninfected, 21 received adjuvant only. Vaccine recipients developed lymphoproliferative responses on 2 or more occasions more often to homologous HIV-1 antigens than did adjuvant recipients (56% vs 14%, p<0.001). Responses were appreciated at 2 months of age, after 2 immunizations, and maintained for more than 84 weeks after the last immunization. An accelerated immunization schedule ( birth, 2 weeks, 2 and 5 months) with the lowest dose of the SF-2 vaccine produced responses in all 11 vaccinees by 4 weeks. Responses to heterologous envelope antigens were also detected. Immune responses to vaccination is achievable at an age when some infection (perinatal and via breast milk exposure) may be prevented.
Showing the most recent 10 out of 1014 publications